Close Menu
SPS COSSPS COS
  • K-Beauty
  • Makeup
  • Skincare
  • Hair and Body Care
  • Shopping
Instagram LinkedIn
  • Contact
  • Privacy Policy
Instagram LinkedIn
SPS COSSPS COS
  • K-Beauty
  • Makeup
  • Skincare
  • Hair and Body Care
  • Shopping
Subscribe
SPS COSSPS COS
erase-dark-circles-dermatologist-eye-cream-tip-1-image
erase-dark-circles-dermatologist-eye-cream-tip-1
Skincare

Why Eye Cream Goes First in the Routine, Not Last

2025-12-10Updated:2026-08-04No Comments6 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

The dermatologist tip that keeps resurfacing in under-eye content is small enough to sound like nothing: apply the eye cream straight after cleansing, before moisturiser and before any serum. Not at the end of the routine, which is where most people put it.

The reasoning is mechanical rather than magical. Skin over the orbital bone is thin, and high-concentration actives applied directly to it — retinol and ascorbic acid in particular — are a common source of stinging and flaking. Going first with a lighter, buffered layer puts something between that skin and the stronger steps that follow. It also stops the actives you actually bought for the eye area from having to push through an occlusive cream to reach anything.

Why the eye cream goes first, not last

Most formulas for this area are not dosed aggressively, and that’s deliberate. A brand formulating for the periocular area is working inside a narrower tolerance window than it would for cheeks or forehead, so the win has to come from placement and consistency rather than from strength.

The application detail that travels with the tip is a grain-of-rice amount per eye, tapped along the orbital bone from the outer corner inward, on both the under-eye and the lid. Patting rather than rubbing. The point of the patting isn’t ritual — dragging thin skin is how people give themselves the irritation they were trying to treat.

What the actives are each doing

Dark circles are not one condition, which is why ingredient lists in this category tend to look like committees. The usual components split fairly cleanly by mechanism:

  • Caffeine — vasoconstrictor, which is why it shows up in formulas aimed at puffiness and the bluish congestion type of shadow rather than at pigment.
  • Vitamin C — works on discolouration and evenness; the same logic behind a brightening serum, at a gentler dose.
  • Peptides — support collagen production, which is the structural side of the problem rather than the colour side.
  • Retinol — accelerates cell turnover, and is the ingredient most likely to be the reason a formula needs buffering in the first place.
  • Vitamin K — paired with caffeine in circulation-focused formulas.

Bakuchiol appears increasingly as the retinol alternative in this category, aimed at buyers who want the turnover story without the tolerance problem.

Worth noting what none of these do. Shadowing caused by the orbital bone structure itself — a deep-set socket casting a shadow — is anatomy, not pigment or fluid, and no topical formula addresses it. Neither does the hollowing that comes from fat pad volume loss. A meaningful share of people who buy into this category are treating a structural feature with a chemical tool, which is the main reason satisfaction rates here run lower than in almost any other skincare segment.

Match the formula to the cause, not the claim

Shadowing under the eyes comes from pigmentation, from fluid retention, from vascular congestion showing through thin skin, or from some combination. A pigment-led circle will not respond much to a caffeine-heavy formula, and a puffiness-led one will not respond much to a brightening one. Nothing on the front of an eye cream box tells you which you have.

For dry skin with visible fine lines, the useful category is closer to a hydration-first product with peptides than to a brightener — which is also where an anti-aging eye serum and a cream start to overlap in function. Texture and vehicle matter here as much as the active list, because a formula that pills under concealer gets abandoned in week two regardless of what’s in it.

The other honest caveat: visible change from any eye cream is slow. Six to eight weeks of consistent use is the timeframe usually cited before anything is fairly assessable, and that gap between purchase and result is the single biggest driver of abandonment in eye care.

The category is no longer a line extension

Eye care used to be the last SKU a brand added once the serum and moisturiser were selling. That order has flipped for a lot of newer brands, and the reasons are commercial rather than dermatological.

The under-eye area now carries its own purchase occasion. Consumers who own a K-beauty eye patch habit already treat the area as a separate routine step with a separate budget, and an eye cream slots into that habit without needing to be explained. That’s a considerably shorter sell than convincing someone to add a ninth step.



If you’re developing in this category

A few things follow from the above for anyone briefing a manufacturer on an eye cream.

Decide which mechanism you’re targeting before you decide the active list. A brief that asks for brightening, de-puffing and firming in one 15ml jar usually comes back as a formula that does none of them at a meaningful level, because every active has been diluted to fit alongside the others.

Specify the layering position on pack. If the product is designed to sit first in the routine, the packaging and the instructions need to say so — otherwise consumers default to applying it last and the buffering logic is lost. This is a copy decision, but it has formulation consequences, because a product meant to go under a retinol serum needs a different vehicle than one meant to seal a routine.

Plan the claim timeline against the 6–8 week reality rather than against the marketing calendar. Brands that set a four-week expectation in launch copy generate returns and negative reviews at exactly the point where the product was starting to work.

And treat the sensitivity constraint as a positioning asset. A formula that a dermatologist-informed buyer can look at and see restraint in — low irritation potential, clear mechanism, no kitchen-sink actives list — reads as more credible in this category than one loaded with everything available.

“In our work with brands sourcing eye care formulations, we’re seeing buyers ask for fewer generic ‘anti-aging’ claims and more specific, layered routines — targeted actives for pigmentation versus puffiness, and packaging that signals a clinical, dermatologist-informed positioning. Eye care used to be an afterthought in a brand’s line-up; now it’s often one of the first categories new brands ask us to help develop, because consumers increasingly treat the under-eye area as its own skincare category with its own purchase occasion.” — Hyejin Cho, Digital Marketing Specialist, Marketing and Communication Team at SPSCOS

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleGlycolic Acid Scrub Briefs Shifted From Strength to Safety
Next Article K-Beauty’s Hottest Skincare Ingredients in 2026 — Here’s What to Launch Your Brand With

Related Posts

Retinal Restriction Australia: What to Check

2026-09-04

Sunscreen SPF Testing Scandal: 3 Checks Before You Manufacture

2026-09-02

Glycolic Acid Scrub Briefs Shifted From Strength to Safety

2025-12-08
Leave A Reply Cancel Reply

Latest Posts

Retinal Restriction Australia: What to Check

2026-09-04

Sunscreen SPF Testing Scandal: 3 Checks Before You Manufacture

2026-09-02

Saudi Arabia Just Banned Syringe-Style Cosmetic Packaging — Here’s What Exporters Need to Know

2026-08-19

K-Beauty’s Hottest Skincare Ingredients in 2026 — Here’s What to Launch Your Brand With

2026-08-12
ABOUT US
ABOUT US

mnc@spscos.com
82-70-8286-9801

Instagram LinkedIn
OUR PICKS

Retinal Restriction Australia: What to Check

2026-09-04

Sunscreen SPF Testing Scandal: 3 Checks Before You Manufacture

2026-09-02

Saudi Arabia Just Banned Syringe-Style Cosmetic Packaging — Here’s What Exporters Need to Know

2026-08-19
MOST POPULAR

Men’s Moisturizer Briefs: Fewer Steps as a Formulation Limit

2025-07-18

Oral Retinol: Why Ingestible Beauty Needs Two Factories

2025-07-02

Semi-Matte Foundation and the Shade Matching Fight

2025-09-17
  • Contact
  • Privacy Policy
© 2026 SPS TIMES. ALL RIGHTS RESERVED.

Type above and press Enter to search. Press Esc to cancel.